Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

FDA expands mutual reliance and harmonization with foreign regulators for inspectional oversight

The U.S. Food and Drug Administration’s (FDA) commitment to expand mutual reliance with trusted regulatory partners may be a silver lining for biomedical innovation during an...

News

FDA issues guidance on conducting remote interactive evaluations during the COVID-19 pandemic

On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring...

Media Mention

GP-led Secondaries Report 2021 Private Equity International

In a recent report produced by Private Equity International, Ed Harris and Adam Brown comment on the expanding GP-led secondaries market, including restructurings, continuation funds and...

News

Increased use of virtual tools, optimized inspectional activities, & enhanced supply chain oversight

The COVID-19 pandemic has resulted in an unprecedented disruption to the U.S. Food and Drug Administration (FDA) inspection program. With the vast majority of its inspectional activities on ...

News

Biotech & Digital Medicine Showcase: Life sciences firms advised on regulatory concerns, investing

Last week, Hogan Lovells partners Alice Valder Curran, Jodi K. Scott, and Jon Layman convened with other industry leaders virtually at this year’s Biotech and Digital Medicine...

Published Works

GP-led transactions are in good health Estates Gazette

In a recent article for Estates Gazette, Ed Harris, Sian Owles, Nicholas Holman, Adam Brown and Elliot Weston explore what GP-led transactions are, the common motivations for their...

Analysis

Private fund preferred equity and NAV financing opportunities and risks
Registered Content

Sovereign investors in private funds will be hearing increasingly of preferred equity and NAV financing, especially as a response to the market slowdown caused by the COVID-19 pandemic.

News

DABUS and the dawn of AI inventors: “the topic that patent lawyers should be monitoring”

In a recent Managing IP article, Imogen Ireland and Jason Lohr examined the recent decisions on “DABUS” to show why AI inventors are not just a future problem

Published Works

COVID-19 and fund secondaries – how should pension schemes position themselves? Investment & Pensions Europe

Partners Ed Harris, Jeremy Pickles, Faye Jarvis and Adam Brown co-wrote an Investment & Pensions Europe article which focusses on how pension funds can best position themselves to take...

Loading data